Article
The manganese superoxide dismutase Val16Ala polymorphism is associated with decreased risk of diabetic nephropathy in Chinese patients with type 2 diabetes.
Molecular and cellular biochemistry - 1 Feb 2009
Liu Limei, Zheng Taishan, Wang Niansong, Wang Feng, Li Ming, Jiang Jiamei, Zhao Ruie, Li Lifang, Zhao Weijing, Zhu Qihan, Jia Weiping
Abstract excerpt
The aim of the present study was to evaluate the relationship of the manganese superoxide dismutase (MnSOD) Val16Ala (V16A) polymorphism with type 2 diabetes mellitus (T2DM) and diabetic nephropathy (DN) in Chinese patients, a case-control study was performed. This case-control study included 172 non-diabetic (non-DM) subjects and 257 T2DM patients with or without DN. Among T2DM patients, 154 had DN [albumin...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
